TIAA CREF Investment Management LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.0% during the 4th quarter, HoldingsChannel reports. The firm owned 4,589,149 shares of the company’s stock after selling 46,568 shares during the period. TIAA CREF Investment Management LLC’s holdings in Colgate-Palmolive were worth $346,251,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Jacobi Capital Management LLC boosted its position in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Virtue Capital Management LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth $104,000. Krilogy Financial LLC boosted its position in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Captrust Financial Advisors purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $122,000. Finally, Bruderman Asset Management LLC purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $126,000. Institutional investors own 73.87% of the company’s stock.
In related news, Vice Chairman Franck J. Moison sold 142,979 shares of the business’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $70.09, for a total value of $10,021,398.11. Following the completion of the transaction, the insider now owns 224,027 shares of the company’s stock, valued at approximately $15,702,052.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jennifer Daniels sold 902 shares of the business’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total transaction of $68,389.64. Following the completion of the transaction, the insider now directly owns 37,788 shares of the company’s stock, valued at approximately $2,865,086.16. The disclosure for this sale can be found here. Insiders sold a total of 455,707 shares of company stock worth $32,443,427 over the last quarter. Insiders own 1.02% of the company’s stock.
Several equities research analysts have commented on CL shares. BNP Paribas lowered shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Tuesday, December 19th. Deutsche Bank started coverage on shares of Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Citigroup boosted their target price on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 30th. Finally, KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the company’s stock. Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $77.91.
Shares of Colgate-Palmolive (NYSE:CL) opened at $70.87 on Wednesday. Colgate-Palmolive has a 1 year low of $68.19 and a 1 year high of $77.91. The company has a quick ratio of 1.00, a current ratio of 1.36 and a debt-to-equity ratio of 27.02. The company has a market cap of $62,218.23, a PE ratio of 31.08, a P/E/G ratio of 2.63 and a beta of 0.79.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.75 EPS for the quarter, hitting the consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. During the same period in the previous year, the firm earned $0.75 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Investors of record on Friday, April 20th will be given a $0.42 dividend. The ex-dividend date is Thursday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a dividend yield of 2.37%. Colgate-Palmolive’s payout ratio is currently 70.18%.
ILLEGAL ACTIVITY NOTICE: This report was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://ledgergazette.com/2018/03/14/tiaa-cref-investment-management-llc-has-346-25-million-position-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.